SHP465 regulatory update

FDA accepted for review a resubmitted NDA for SHP465 from Shire to treat ADHD. Its PDUFA date is June 20. Shire first submitted the NDA in 2006 to treat adult ADHD. Shire hopes to launch SHP465 next h...